INTRODUCTION
made in the pre-marked quadrants, precisely penetrating 3 mm inside the anal verge (marked by the 112 blocker around the syringe). (These landmarks were determined via rectoanal intraluminal manometry 113 that recorded the highest pressure in the IAS, as explained later.) During the procedure, a cylindrical 114 magnetic bead (5 mm OD, and 10 mm long) was placed lengthwise in the anal region for 20 min to 115 simulate a magnetic field. At 24, 48, and 72 hr later, rectoanal manometry was performed to measure the 116 basal intraluminal IAS pressures (IASP) (Figs. 1, 2) . 117
Measurements of intraluminal pressures of the IAS. Rectoanal manometry was employed to
118 study the in vivo functional status of IAS before and after application of miR-139-5p following the 119 modified version of the previously described approach (4, 24, 30). The IASP was measured in 120 anaesthetized rats (initially anesthetized with 5% isoflurane followed by maintenance with 1% isoflurane, 121 throughout the length of the experiment). As pressure sensors, solid-state transducers/catheters with a 2-122
Fr Mikro-Tip were used (Millar Instruments, Houston, TX) (37). Rectoanal manometry was performed to 123 measure the basal IASP. The catheter assembly was initially introduced into the rectum, and then 124 positioned precisely in the IAS via slow pull-through (approximately 7-8 mm from the anal verge). The 125 IAS was identified by the precise zone that recorded the highest pressure in the anal area. The IASP, 126 which represents small rhythmic fluctuations superimposed on the steady high pressures that correlate 127 with basal IAS tone in in vitro setting for force recording, was recorded using a PowerLab/8SP recorder 128 and analyzed via the software Chart 4 PowerLab (ADInstruments, Inc., Colorado Springs, CO). 129 canal, cut transversely into 5 mm long tubular sections and carefully placed into blocks containing OCT(cryo-embedding media) and the entire tissue block submerged into liquid nitrogen. 136
The tissues were subsequently processed for embedding, sectioning with cryostat, and tissue 137 processing at Thomas Jefferson University Histopathology Core facility. 15m thick transverse sections 138 were cut and kept in dark box to protect the photo bleaching of FITC-tagged siRNA. These sections were 139 then washed three times with phosphate-buffered saline/Tween (PBST) and fixed with Prolong Diamond 140 antifade mounting media (Life Technologies, Carlsbad, CA) and viewed under confocal microscope 141 (Nikon A1R, Nikon Instruments, NY), and photographs were taken and analyzed with ImageJ2 (NIH). 142
Force measurement. The IAS smooth muscle strips from respective groups (described above 143 under Animals) were employed for the recording of force, as previously described (30, 31). Briefly, the 144 IAS smooth muscle strips (~1 x 10 mm) isolated from circular smooth muscle (CSM) layer of the IAS 145 were cleaned and mounted in 2-ml muscle baths under 1.0 g tension maintained at 37C and 7.4 pH, 146 under constant aeration with Carbogen (95% CO 2 + 5% O 2 ). The smooth muscle strips were repeatedly 147 washed with fresh Krebs physiological solution (KPS) every 20 min. The composition of the KPS in mM 148 was: 118.07 NaCl, 4.69 KCl, 2.52 CaCl 2 , 1.16 MgSO 4 , 1.01 NaH 2 PO 4 , 25 NaHCO 3 , and 11.1 glucose. 149
Following a 1-hr equilibration period, the smooth muscle strips developed spontaneous tone. This basal 150 tone and its changes in response to different treatments were monitored using sensitive force transducers 151 (FORT10, WPI, Sarasota, FL), and data were recorded using Chart 4.1.2 via a PowerLab/8SP data-152 acquisition system (ADInstruments, Colorado Springs, CO). The spontaneously developed basal IAS 153 tone, and its maximal decrease and increase were recorded in response to 0 Ca 2+ and 100 µM bethanechol, 154 respectively, at the beginning and at the end of each experiment. The relaxant responses to electrical field 155 stimulation (EFS) (0 V, 0.5-ms pulse duration, and 4 s of train duration with frequencies ranging fromstandardized procedure in our laboratory (30, 34), with some modifications. Briefly, IAS smooth muscle 160 strips were flash-frozen into liquid nitrogen, homogenized in ice-cold homogenization buffer (10 mM Tris 161
HCl, pH 7.5, 5 mM MgCl 2 , 2 mM EDTA, 250 mM sucrose, and 1 mM dithiothreitol, 1% Triton X-100), 162 centrifuged (800 g for 10 min), and then protein concentration quantified in the resultant supernatant 163 using BCA Protein Assay Reagent Kit (Pierce Biotechnology, Rockford, IL). Next, 20 μg of protein in 20 164 μl of lysates were mixed with 2x Laemmli sample buffer (LSB; with final concentrations of 62.5 mM 165
Tris, 1% SDS, 15% glycerol, 0.005% bromophenol blue, and 2% mercaptoethanol) and boiled in hot 166 water bath for 5 min. The total proteins in the samples were separated by SDS-polyacrylamide gel, 167 transferred electrophoretically to a polyvinylidene difluoride (PVD) membrane, and treated with LI-COR 168 blocking buffer. The membranes were then incubated with the specific primary antibodies (1:1,000 for 169
RhoA, ROCK2, MYPT1, p-MYPT1, MLC 20 , p-MLC 20 , and 1:20,000 for GAPDH) diluted in LI-COR 170 buffer containing 0.1% Tween-20 overnight at 4 C. After washing thrice with TBS-T (each for 10 min), 171 the membranes were incubated with the IRdye680 and IRdye800 conjugated secondary antibody from LI-172 COR Biosciences in the dark (donkey anti-rabbit 1:10,000 for ROCK2, MYPT1, p-MYPT1; donkey anti-173 goat 1:10,000 for p-MLC 20 ; and donkey anti-mouse 1:10,000 for RhoA, MLC 20 , and GAPDH). The 174 membranes were washed (three times for 10 min) with TBS-T and finally kept in PBS buffer on shaker 175
for 10 min at RT in the dark and scanned by LI-COR Infrared scanner (LI-COR Biosciences). 
RESULTS

189
Efficiency of in vivo magnetofection. To validate the MF approach, the siRNA transfection 190 efficiency of in vivo MF was determined via confocal microscopy by Fl-siRNA in IAS, using a standard 191 immunohistochemistry approach following perianal injections vs. MF, as described in the Methods. To further validate the MF approach, we used microRNA-139-5p and anti-microRNA-139-5p, which 197 are known to target ROCK2 in different systems (38) and in vitro studies in the rat IAS (33). We 198 performed functional and Western blot studies using microRNA-139-5p and anti-microRNA-139p MF 199 alone or in combination. Based on our prior experience (30, 33), and from literature (11, 27, 28, 39), we 200 conducted further optimization studies that indicated that the optimal dose for these oligomirs in vivo 201 studies was single perianal injection within the IAS of 100 nM in 100 µl, following which different 202 parameters were monitored after 72 hr . The rest of the experimental protocols were carried out following 203 this MF strategy for in vivo studies, in vitro functional studies, and signal transduction studies (Fig. 2) . Interestingly, rats magnetofected with microRNA-139p had a higher fecal pellet count/24 h (73.5 ± 211
1.4 pellets, averaged from total collection of 96 h following the treatment) compared to controls (54.2 ± 212 1.6) (*; p < 0.05; n = 4; Fig. 4B ), in reverse correlation with the corresponding decrease in the IASP. 213
Additionally, the microRNA-139-5p-induced increase in the pellet count was blocked by anti-microRNA-214 139-5p, which by itself induced a significant decrease (*; p < 0.05; n = 4). 215
The IAS muscle strips isolated following miRNA-139-5p MF showed a significant decrease in basal 216 IAS tone (*; p < 0.05; n = 4; Fig. 4C ). This decrease was attenuated by anti-microRNA-139-5p to levels 217 not significantly different from the control (p > 0.05). Of further significance, MF with anti-miRNA-139-218 5p by itself caused a significant increase in the IAS tone (*; p < 0.05; Fig. 4C ). Collectively, these 219 functional data suggest the selectivity and targeted effect of the MF approach using miRNA-139-5p in the 220
IAS. 221
Effect of miR-139-5p and anti-miR-139-5p on IAS smooth muscle relaxation and Krebs physiological solution, respectively. Interestingly, anti-microRNA-139-5 had the opposite effects 226 that increased these rates of the smooth muscle relaxation and recovery ( Fig. 5A-D) . 227
Effect of miR-139-5p and anti-miR-139-5p on EFS (5 Hz)-induced IAS relaxation and
228 recovery kinetics. Conversely, anti-miRNA-139-5p alone had an effect opposite to that of miRNA-139-5p: it caused a 245 significant leftward shift in the U46619 concentration-response curve (p > 0.05; n = 4; Fig. 7B ). 246
Collectively, these findings demonstrate that miR-139-5p compromises the fibroelastic properties of 247 the IAS smooth muscle, and that compromise can be rescued by anti-microRNA-139-5p. 
DISCUSSION
258
The present studies for the first time demonstrate the success of topical in vivo MF of nucleic acids 259 using perianal injections via an optimized protocol. To demonstrate whether this treatment approach is 260 effective, we used FITC-tagged siRNA using immunofluorescence microcopy and collected detailed 261 functional and biochemical evidence using miR-139-5p, which is known to target ROCK2, a primary 262 molecular determinant of the basal IAS tone. Data revealed that topical in vivo MF allows safe, 263 convenient, efficient, robust, and targeted delivery of oligonucleotides such as siRNAs and microRNAs, 264
suggesting that the approach holds potential for treating patients with IAS-associated rectoanal motility 265 disorders. The implications of research apply not only to the treatment of rectoanal motility disorders, but 266 also to the treatment of other systems that require the topical use of such molecules. 267
Previous studies in different systems (7, 10, 29) have shown that miR-139-5p regulates a number of 268 molecular functions by targeting ROCK2. And more recent in vitro studies from our laboratory further 269 supported the concept that this miRNA regulates the tonicity of the IAS smooth muscle by targeting 270 ROCK2 (30). Our current studies significantly advance on this work by showing that when miR-139-5p is 271 topically delivered to the circular smooth muscle layer, it remains primarily contained in the IAS, thus 272 minimizing the systemic side effects. Besides, ROCK2, it is known that miR-139-5p may also target other 273 genes such as Brg1, a chromatin remodeling factor (42), Bmi1,c-MYC, NANOG, OCT4, and KLF4/Wnt 274 (13), Runx/PTEN-PI3K-AKT (5), and PPAR γ and FAS and Notch/PI3K/Akt insulin signaling pathways 275 (16). Exact role of these pathways in the IAS function, however, remains to be determined. 276
To determine the efficiency and safety of this MF method for gene delivery, we conducted IASconfirmed the uptake of FIsiRNA into the smooth muscle layers, showing especially the highest 279 distribution in the circular smooth muscle layer without any evidence of cellular damage. These results 280 indicated that in vivo MF using PolyMag is an efficient and safe approach for delivering large molecules 281 such as the siRNAs and miRNAs directly to the affected site. 282
To further substantiate the success of MF for the delivery of nucleotides, we obtained functional and 283 biochemical evidence using oligomiR-139-5p for overexpressing and antagomiR-139-5p for 284 downregulating miR-139-5p (Figure 2) . In vivo functional data revealed that miR-139-5p MF decreases 285 the basal IASP while the anti-miR has the opposite effect of increasing it. These changes in basal IASP 286 correlate with reverse correlation in the fecal pellet output, which was reflected by an increase in pellets 287
with the miR-139-5p and a decrease with the anti-miR compared to the control and the combined use of 288 the miR and anti-miR. These findings indicate that hypertensive IAS may be rescued by the perianal MF 289 of miR-139-5p while hypotensive IAS may be restored by the respective anti-miR. 290
The functional evidence that we collected on the in vivo MF delivery of nucleic acids agrees with in 291 vitro data on basal tone with miRNA-139-5p and anti-miR compared to controls. Additionally, the data 292 that we collected with the time course experiments revealed that the overall speed of contraction 293 following U46619 is slower following miRNA-139-5p MF and faster following anti-miR. We obtained 294 similar data when determining the rates of relaxation following 0 Ca 2+ , and recovery of smooth muscle 295 tone following Ca 2+ replenishment. Interestingly, the relaxation and recovery time course data are 296 strikingly similar to those with the EFS and have strong implications for the fibroelastic properties of the 297 IAS that may be partly responsible for the IAS tone and its relaxation. Such data agree with previous 298 reports suggesting that miR-139-5p targets the matrix metalloprotease, which may lead to compromise in 299 the fibroelastic properties of the smooth muscle (36, 40, 43). We and others have reported that FEP may 300 Conversely, a further decrease in already low basal levels of miRNA-139-5p may be implicated in 319 hypertensive IAS and other associated rectoanal motility disorders. We showed that anti-miRNA-139-5p 320 that increases basal IASP is associated with decreases in fecal output that could be negated by miR MF. 321
The MF approach offers a major advantage of containing the miRNA and its anti-miR in the IAS where it 322 is applied, reducing systemic side effects, including those that could lead to indirect and unpredictable 323 effects in the IAS smooth muscle. The containment of such molecules was evident from the restricted 324 distribution of siRNA MF in the circular smooth muscle layer within the IAS. 325
In conclusion, our findings demonstrate the efficiency of a novel method of targeted nucleic acid 326 delivery via MF. In an example of its application, we used MF to deliver microRNA-139-5, which is 327 known to target ROCK2, to the IAS. Our results suggest that by restoring basal IAS tone and the 
